Determinants of cervical cancer screening uptake in Lesotho: evidence from 2024 Demographic and Health Survey data
- PMID: 40615793
- PMCID: PMC12231998
- DOI: 10.1186/s12889-025-23593-4
Determinants of cervical cancer screening uptake in Lesotho: evidence from 2024 Demographic and Health Survey data
Abstract
Introduction: Cervical cancer affects approximately 13.1 women per 100,000 globally, with its incidence rates varying significantly across regions. Low- and middle-income countries bear the highest burden, partly due to inadequate access to preventive measures, such as regular screening and timely treatment. This study aims to identify the determinants of cervical cancer screening uptake among women of reproductive age in Lesotho, using data from the most recent Demographic and Health Survey.
Methods: A total of 3,250 women were included in this study, utilizing data from the 2024 Lesotho Demographic and Health Survey. The analysis was conducted using STATA version 17.0. A multilevel mixed-effects logistic regression model was employed to identify potential factors associated with the outcome variable. Variables with p-values less than 0.05 were considered statistically significant.
Result: The practice of cervical cancer screening was found to be 38.90% [95% CI: 37.20-40.60]. The odds of cervical cancer screening uptake were significantly higher among women aged 20-49 years compared to those aged 15-19 years. Women with primary and secondary education levels were approximately 5.8 times more likely to undergo screening [AOR = 5.779, 95% CI: 1.1-30.0 and AOR = 5.79, 95% CI: 1.0-30.6], respectively, than women with no formal education. At the community level, women with high media exposure were 1.6 times more likely to be screened [AOR = 1.56, 95% CI: 1.05-2.33] compared to those with low media exposure.
Conclusion: Cervical cancer screening rates were found to be low in this study. To encourage screening behavior, raising awareness through accessible media platforms and providing education to women could be effective. Additionally, older age was identified as a factor positively associated with screening uptake. The government should prioritize cervical cancer prevention and screening, as it remains the most cost-effective method for preventing cervical cancer.
Keywords: Cervical cancer; Demography and health survey; Lesotho; Screening uptake.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: After the consent letter was submitted to the DHS Programmers/ICF to download the dataset for this investigation, the International Review Board of Demographic and Health Surveys (DHS) program data archivists waived informed consent. The datasets came from a publicly accessible source, and therefore it is not an experimental study. All the methods were conducted according to the Helsinki Declarations. More details regarding DHS data and ethical standards are available online at ( http://www.dhsprogram.com ). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Interventions targeted at women to encourage the uptake of cervical screening.Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3. Cochrane Database Syst Rev. 2021. PMID: 34694000 Free PMC article.
-
Cervical cancer screening uptake in Côte d'Ivoire: Analysis of prevalence and associated factors.BMC Public Health. 2025 Jul 2;25(1):2287. doi: 10.1186/s12889-025-23103-6. BMC Public Health. 2025. PMID: 40604672 Free PMC article.
-
Cervical cancer screening uptake among women living with HIV in the era of universal test and treat policy in Malawi: results from the 2020-2021 Malawi population-based HIV impact assessment.BMC Cancer. 2025 Jul 1;25(1):1052. doi: 10.1186/s12885-025-13436-1. BMC Cancer. 2025. PMID: 40597781 Free PMC article.
-
Utilization of cervical cancer screening and its associated factors among women living with HIV in East Africa: a systematic review and meta-analysis.BMC Womens Health. 2025 Jul 4;25(1):326. doi: 10.1186/s12905-025-03880-3. BMC Womens Health. 2025. PMID: 40616026 Free PMC article.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
References
-
- Cancer. I.A.f.R.o., World Health Organization Global Cancer Observatory: Cancer Today. 2023.
-
- Organization WH. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. World Health Organization; 2021. - PubMed